• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过收缩期时间间期评估早期阿霉素诱导的心脏毒性。

Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals.

作者信息

Villani F, Beretta G, Guindani A

出版信息

Cancer Chemother Pharmacol. 1979;3(4):249-51. doi: 10.1007/BF00254740.

DOI:10.1007/BF00254740
PMID:535135
Abstract

Systolic time intervals (PEP/LVET ratio) were used for detection of acute variations in myocardial contractility after a single dose of 30, 60, or 75 mg of doxorubicin/m2. This drug induces an acute impairment of left ventricular function (increase in the PEP/LVET ratio) detectable 1 h after doxorubicin injection. The phenomenon appears to be dose-related, with a threshold dose of 30-40 mg/m2. The decrease in myocardial contractility is fully reversible within 24 h, at least after the first dose. This kind of evaluation appears applicable to phase I studies of new anthracycline derivatives.

摘要

采用收缩期时间间期(PEP/LVET 比值)来检测单次给予 30、60 或 75mg 多柔比星/平方米后心肌收缩力的急性变化。该药物可导致左心室功能急性受损(PEP/LVET 比值升高),在多柔比星注射后 1 小时即可检测到。这种现象似乎与剂量相关,阈值剂量为 30 - 40mg/平方米。心肌收缩力的降低在 24 小时内可完全恢复,至少在首次给药后是这样。这种评估似乎适用于新蒽环类衍生物的 I 期研究。

相似文献

1
Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals.通过收缩期时间间期评估早期阿霉素诱导的心脏毒性。
Cancer Chemother Pharmacol. 1979;3(4):249-51. doi: 10.1007/BF00254740.
2
Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.以收缩期时间间期为指标评估急性髓性白血病患者依化疗方案的阿霉素心脏毒性。
Br Med J. 1979 May 26;1(6175):1392-5. doi: 10.1136/bmj.1.6175.1392.
3
Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.儿童长期阿霉素心脏毒性:收缩状态和舒张期充盈的无创评估
Br Heart J. 1988 Oct;60(4):309-15. doi: 10.1136/hrt.60.4.309.
4
Adriamycin cardiotoxicity. Prognostic value of the systolic time intervals.阿霉素心脏毒性。收缩期时间间期的预后价值。
Acta Cardiol. 1982;37(2):105-15.
5
Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.4'-脱氧阿霉素心脏毒性的临床评估
Int J Clin Pharmacol Ther Toxicol. 1988 Apr;26(4):185-9.
6
[Determination of systolic time intervals in healthy and in adriamycin-treated children].
Klin Padiatr. 1984 Nov-Dec;196(6):360-6. doi: 10.1055/s-2008-1034096.
7
Assessment of left ventricular contractility in patients receiving doxorubicin.接受阿霉素治疗患者左心室收缩性的评估。
Ann Intern Med. 1983 Dec;99(6):750-6. doi: 10.7326/0003-4819-99-6-750.
8
[Monitoring of Myocardial function during therapy with cardiotoxic cytostatics. Studies with the example of anthracycline-containing chemotherapy].[心脏毒性细胞抑制剂治疗期间的心肌功能监测。以含蒽环类化疗为例的研究]
Onkologie. 1982 Aug;5(4):168-73. doi: 10.1159/000214994.
9
Evaluation of doxorubicin cardiotoxicity in patients treated intermittently with beta-methyldigoxin.对接受β-甲基地高辛间歇治疗的患者进行阿霉素心脏毒性评估。
Tumori. 1982 Aug;68(4):349-53. doi: 10.1177/030089168206800414.
10
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.
Ann Intern Med. 1978 Feb;88(2):168-75. doi: 10.7326/0003-4819-88-2-168.

引用本文的文献

1
The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.阿霉素(DOX)和聚乙二醇化脂质体阿霉素对携带C-26结肠癌小鼠的心脏毒性机制:一项聚焦于微小RNA在新制剂毒性评估中作用的研究
Pharm Res. 2017 Sep;34(9):1849-1856. doi: 10.1007/s11095-017-2194-3. Epub 2017 May 30.
2
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.蒽环类抗肿瘤药物。物理化学、分析及稳定性性质综述。
Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146.
3
Hemodynamic effects of chronic 4'epi-adriamycin administration.

本文引用的文献

1
Systolic time intervals in heart failure in man.人类心力衰竭时的收缩期时间间期
Circulation. 1968 Feb;37(2):149-59. doi: 10.1161/01.cir.37.2.149.
2
[Polycardiographic evaluation of the cardiotoxicity of adriamycin].
G Ital Chemioter. 1975 Jan-Dec;22(1-2):39-46.
3
Serial studies of cardiac function in patients receiving adriamycin.
Cancer Treat Rep. 1978 Jun;62(6):923-9.
4
长期给予4'-表阿霉素的血流动力学效应。
Cardiovasc Drugs Ther. 1990 Dec;4(6):1519-23. doi: 10.1007/BF02026501.
Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
小儿蒽环类药物所致心肌病监测中的收缩期时间间期
Cancer Treat Rep. 1978 Jun;62(6):907-10.
5
Systolic time intervals in monitoring adriamycin-induced cardiotoxicity.监测阿霉素诱导心脏毒性中的收缩期时间间期。
Cancer Treat Rep. 1978 Jun;62(6):893-9.
6
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.评估阿霉素对人体心脏毒性作用的有创和无创方法:采用心内膜心肌活检进行组织病理学评估的优越性。
Cancer Treat Rep. 1978 Jun;62(6):857-64.
7
Influence of adriamycin on calcium exchangeability in cardiac muscle and its modification by ouabain.阿霉素对心肌钙交换性的影响及其被哇巴因的修饰作用。
Biochem Pharmacol. 1978 Mar 15;27(6):985-7. doi: 10.1016/0006-2952(78)90429-x.
8
Echocardiographic assessment of left ventricular function during the injection of adriamycin.阿霉素注射期间左心室功能的超声心动图评估
Acta Paediatr Scand. 1977 Sep;66(5):595-600. doi: 10.1111/j.1651-2227.1977.tb07953.x.